Dr. Ricardo A. Yaryura, MD

Dr. Yaryura practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Yaryura's NPI, 1083662266, was assigned on May 4, 2006. Dr. Yaryura graduated from University Saskatchewan Royal Hospital in 1990. Dr. Yaryura holds Florida license ME73423.

Dr. Yaryura's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Yaryura's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Yaryura is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Intercoastal Medical Group. Dmand AI also links Dr. Yaryura to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yaryura practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yaryura's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yaryura is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Yaryura's licenses on file in 3 states: Florida, Texas and New York.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic embolism thrombosis among the conditions Dr. Yaryura treats.

CMS data shows 9,531 Medicare services from Dr. Yaryura across 62 procedure codes in 2024, for 2,854 Medicare patients. Medicare paid $1,112,379 for them.

CMS counts 2,854 Medicare patients who saw Dr. Yaryura in 2024. The largest group is 75 to 84, with 1,318 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yaryura's median patient age at 80, with 41% women.

In 2024, Dr. Yaryura wrote 7,898 Medicare Part D claims for 1,260 patients. 81% of them were for generic drugs. CMS names the drug for 7,611 of them, across 75 drugs with 11 or more claims each, at $1,803,148 in total drug cost. In 2023, CMS named 7,309 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yaryura for performance year 2024, reported individually. Dr. Yaryura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yaryura as offering telehealth. CMS counts 109 procedures of coronary angioplasty and stenting by Dr. Yaryura, more than 97% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Yaryura in 2016. The most frequent topics are Heart Valve Prosthesis, Abciximab and Angioplasty, Balloon, Coronary. Dr. Yaryura has published most often in JACC Cardiovasc Interv. Dr. Yaryura's most frequent co-authors are Hakim Morsli, MD and Jonathan David Hoffberger, DO.

Dmand AI links Dr. Yaryura to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Atherosclerosis, Mitral Valve Insufficiency and Stroke. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 264 general payments to Dr. Yaryura from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Edwards Lifesciences Corporation paid the most, $6,292.

Dmand AI lists 4 awards for Dr. Yaryura, most recently CMS Stage 1 EHR in 2013.

Dr. Yaryura graduated from University Saskatchewan Royal Hospital in 1990. Dr. Yaryura is a member of ACC and ACP.

Dr. Yaryura is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.